# Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study

> **NCT07657299** · — · COMPLETED · sponsor: **Ain Shams University** · enrollment: 30 (actual)

## Conditions studied

- Bladder Cancer
- Bladder Cancer Recurrence

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07657299
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07657299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07657299, "Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07657299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*